Literature DB >> 23254835

Left ventricular synchronicity is impaired in patients with active acromegaly.

Abdulkadir Kırış1, Cihangir Erem, Oğuzhan Ekrem Turan, Nadim Civan, Gülhanım Kırış, Irfan Nuhoğlu, Abdulselam Ilter, Halil Onder Ersöz, Merih Kutlu.   

Abstract

Acromegaly is associated with a variety of cardiovascular disturbances such as left ventricular hypertrophy, diastolic cardiac dysfunction, and hypertension. Left ventricular (LV) dyssynchrony means the impairment of synchronicity and is defined as the loss of the simultaneous peak contraction of corresponding cardiac segments. The objective of this study was to investigate whether acromegalic patients have left ventricular dyssynchrony. Dyssynchrony was evaluated in 30 patients with active acromegaly and 30 controls. All the patients and controls were subjected to a tissue synchronization imaging. The time to regional peak systolic tissue velocity (Ts) in LV by the six-basal-six-mid-segmental model was measured on ejection phase TSI images and four TSI parameters of systolic dyssynchrony were computed. All TSI parameters of LV dyssynchrony increased in patients with acromegaly compared to the controls: the standard deviation (SD) of the 12 LV segments Ts (43.5 ± 13.5 vs 26.2 ± 12.5, p < 0.001); the maximal difference in Ts between any 2 of the 12 LV segments (133.3 ± 38 vs 84.6 ± 37.6, p < 0.001); the SD of the 6 basal LV segments (41.1 ± 15.9 vs 25.4 ± 14.8, p = 0.001); and the maximal difference in Ts between any 2 of the 6 basal LV segments (102.6 ± 37.5 vs 65.2 ± 36.9, p = 0.001). In addition, there were significant relationships between the levels of growth hormone/insulin-like growth factor-1 and Ts-SD-12. LV synchronicity has been impaired in patients with acromegaly. Left ventricular dyssynchrony is associated with disease activity and it may contribute to the harmful cardiovascular effects of acromegaly.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23254835     DOI: 10.1007/s12020-012-9859-9

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  43 in total

1.  Cardiac dysfunction in acromegaly: evidence by pulsed wave tissue Doppler imaging.

Authors:  G Mercuro; S Zoncu; P Colonna; P Cherchi; S Mariotti; F Pigliaru; L Petrini; S Iliceto
Journal:  Eur J Endocrinol       Date:  2000-09       Impact factor: 6.664

2.  Patients with ankylosing spondylitis have evidence of left ventricular asynchrony.

Authors:  Abdulkadir Kırış; Murat Karkucak; Kayıhan Karaman; Gülhanım Kırış; Erhan Capkın; Ferhat Gökmen; Merih Kutlu; Şükrü Çelik; Ahmet Ayar
Journal:  Echocardiography       Date:  2012-03-09       Impact factor: 1.724

Review 3.  Cardiovascular function in acromegaly.

Authors:  R N Clayton
Journal:  Endocr Rev       Date:  2003-06       Impact factor: 19.871

4.  Improved left ventricular relaxation during short-term right ventricular outflow tract compared to apical pacing.

Authors:  T M Kolettis; Z S Kyriakides; D Tsiapras; T Popov; I A Paraskevaides; D T Kremastinos
Journal:  Chest       Date:  2000-01       Impact factor: 9.410

5.  Left ventricular dyssynchrony and its effects on cardiac function in patients with newly diagnosed hypertension.

Authors:  Abdulkadir Kırış; Kayıhan Karaman; Gülhanım Kırış; Mürsel Şahin; Ismet Durmuş; Şahin Kaplan; Asım Örem; Merih Kutlu; Ahmet Ayar
Journal:  Echocardiography       Date:  2012-05-29       Impact factor: 1.724

6.  Improvement of intrinsic myocardial contractility and cardiac fibrosis degree in acromegalic patients treated with somatostatin analogues: a prospective study.

Authors:  Fausto Bogazzi; Vitantonio Di Bello; Caterina Palagi; Maria Grazia Delle Donne; Andrea Di Cori; Silvia Gavioli; Enrica Talini; Chiara Cosci; Chiara Sardella; Sandra Brogioni; Mario Mariani; Enio Martino
Journal:  Clin Endocrinol (Oxf)       Date:  2005-05       Impact factor: 3.478

7.  Assessment of the Tei index by tissue Doppler imaging in patients with acromegaly: serum growth hormone level is associated with the Tei index.

Authors:  Merih Baykan; Cihangir Erem; Omer Gedikli; Arif Hacihasanoğlu; Turan Erdoğan; Mustafa Koçak; Sahin Kaplan; Abdülkadir Kiriş; Sükrü Celik
Journal:  Echocardiography       Date:  2008-01-03       Impact factor: 1.724

8.  Determination of left ventricular mass by echocardiography in a normal population: effect of age and sex in addition to body size.

Authors:  C Shub; A L Klein; P K Zachariah; K R Bailey; A J Tajik
Journal:  Mayo Clin Proc       Date:  1994-03       Impact factor: 7.616

9.  Cardiac hypertrophy and function in asymptomatic acromegaly.

Authors:  D Morvan; M Komajda; A Grimaldi; G Turpin; Y Grosgogeat
Journal:  Eur Heart J       Date:  1991-06       Impact factor: 29.983

10.  Assessment of left ventricular systolic asynchrony in patients with clinical hypothyroidism.

Authors:  Sahin Kaplan; Abdulkadir Kiriş; Cihangir Erem; Tuba Kaplan; Gülhanim Kiriş; Omer Gedikli; Mustafa Koçak; Merih Baykan; Sükrü Celik
Journal:  Echocardiography       Date:  2009-08-31       Impact factor: 1.724

View more
  6 in total

1.  Left ventricular synchronicity in acromegaly.

Authors:  Ludovica F S Grasso; Annamaria Colao
Journal:  Endocrine       Date:  2013-06-27       Impact factor: 3.633

Review 2.  Cardiovascular comorbidities in acromegaly: an update on their diagnosis and management.

Authors:  Ana M Ramos-Leví; Mónica Marazuela
Journal:  Endocrine       Date:  2017-01-02       Impact factor: 3.633

3.  Atrial conduction times and left atrium mechanical functions in patients with active acromegaly.

Authors:  A Ilter; A Kırış; Ş Kaplan; M Kutlu; M Şahin; C Erem; N Civan; F Kangül
Journal:  Endocrine       Date:  2014-07-15       Impact factor: 3.633

Review 4.  Acromegalic cardiomyopathy: Epidemiology, diagnosis, and management.

Authors:  Ajay N Sharma; Marilyn Tan; Ezra A Amsterdam; Gagan D Singh
Journal:  Clin Cardiol       Date:  2018-03-25       Impact factor: 2.882

Review 5.  Electrophysiological features in acromegaly: re-thinking the arrhythmic risk?

Authors:  M Parolin; F Dassie; R Vettor; R P Steeds; P Maffei
Journal:  J Endocrinol Invest       Date:  2020-07-06       Impact factor: 4.256

Review 6.  Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities.

Authors:  Rosario Pivonello; Renata S Auriemma; Ludovica F S Grasso; Claudia Pivonello; Chiara Simeoli; Roberta Patalano; Mariano Galdiero; Annamaria Colao
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.